{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:40:59Z","timestamp":1762101659005},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T00:00:00Z","timestamp":1421452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10014-015-0212-x","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T03:24:09Z","timestamp":1421378649000},"page":"195-201","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression"],"prefix":"10.1007","volume":"32","author":[{"given":"Hasan","family":"Esen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahad\u0131r","family":"Feyzioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Erdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfi Saltuk","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,17]]},"reference":[{"issue":"2","key":"212_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.20733","volume":"114","author":"G Wrobel","year":"2005","unstructured":"Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114(2):249\u2013256","journal-title":"Int J Cancer"},{"key":"212_CR2","first-page":"176","volume-title":"Pathology and genetics of tumours of the nervous system","author":"DN Louis","year":"2000","unstructured":"Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, pp 176\u2013189"},{"issue":"2","key":"212_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1750-3639.2003.tb00015.x","volume":"13","author":"H Haapasalo","year":"2003","unstructured":"Haapasalo H, Kyl\u00e4niemi M, Paunul N, Kinnula VL, Soini Y (2003) Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol 13(2):155\u2013164","journal-title":"Brain Pathol"},{"issue":"4","key":"212_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0032-1333422","volume":"74","author":"R Kemerdere","year":"2013","unstructured":"Kemerdere R, Kacira T, Hanimoglu H, Kucur M, Tanriverdi T, Canbaz B (2013) Tissue and plasma thioredoxin reductase expressions in patients with glioblastoma multiforme. J Neurol Surg A Cent Eur Neurosurg 74(4):234\u2013238","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"issue":"9","key":"212_CR5","first-page":"2693","volume":"31","author":"V Yagublu","year":"2011","unstructured":"Yagublu V, Arthur JR, Babayeva SN, Nicol F, Post S, Keese M (2011) Expression of selenium-containing proteins in human colon carcinoma tissue. Anticancer Res 31(9):2693\u20132698","journal-title":"Anticancer Res"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4161\/cbt.4.1.1434","volume":"4","author":"JE Biaglow","year":"2005","unstructured":"Biaglow JE, Miller RA (2005) The thioredoxin reductase\/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 4:6\u201313","journal-title":"Cancer Biol Ther"},{"key":"212_CR7","first-page":"3459","volume":"16","author":"M Berggren","year":"1996","unstructured":"Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G (1996) Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16:3459\u20133466","journal-title":"Anticancer Res"},{"key":"212_CR8","first-page":"3331","volume":"22","author":"JH Choi","year":"2002","unstructured":"Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR (2002) Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22:3331\u20133335","journal-title":"Anticancer Res"},{"key":"212_CR9","first-page":"3087","volume":"7","author":"S Kakolyris","year":"2001","unstructured":"Kakolyris S, Giatromanolaki A, Koukourakis M, Powis G, Souglakos J, Sivridis E, Georgoulias V, Gatter KC, Harris AL (2001) Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res 7:3087\u20133091","journal-title":"Clin Cancer Res"},{"key":"212_CR10","doi-asserted-by":"crossref","unstructured":"Esen H, Erdi F, Kaya B, Feyzioglu B, Keskin F, Demir LS (2014) Tissue thioredoxin reductase-1 expression in astrocytomas of different grades. J Neurooncol (Epub ahead of print). doi: 10.1007\/s11060-014-1661-5","DOI":"10.1007\/s11060-014-1661-5"},{"key":"212_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-006-9118-0","volume":"77","author":"S J\u00e4rvel\u00e4","year":"2006","unstructured":"J\u00e4rvel\u00e4 S, Bragge H, Paunu N, J\u00e4rvel\u00e4 T, Palj\u00e4rvi L, Kalimo H, Hel\u00e9n P, Kinnula V, Soini Y, Haapasalo H (2006) Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival. J Neurooncol 77:131\u2013140","journal-title":"J Neurooncol"},{"key":"212_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.freeradbiomed.2005.09.031","volume":"40","author":"R Ahmadi","year":"2006","unstructured":"Ahmadi R, Urig S, Hartmann M, Helmke BM, Koncarevic S, Allenberger B, Kienhoefer C, Neher M, Steiner HH, Unterberg A, Herold-Mende C, Becker K (2006) Antiglioma activity of 2,2\u2032:6\u2032,2\u2032\u2032-terpyridineplatinum[II] complexes in a rat model-effects on cellular redox metabolism. Free Radic Biol Med 40:763\u2013778","journal-title":"Free Radic Biol Med"},{"key":"212_CR13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2007.04.017","volume":"69","author":"JM Ford","year":"2007","unstructured":"Ford JM, Seiferheld W, Alger JR, Wu G, Endicott TJ, Mehta M, Curran W, Phan SC (2007) Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 69:831\u2013838","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"212_CR14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3892\/ol.2013.1556","volume":"6","author":"T Huang","year":"2013","unstructured":"Huang T, Jin X, He L, Zhang M, Wu J, Wang Y, Fang J (2013) Role of podocalyxin in astrocytoma: clinicopathological and in vitro evidence. Oncol Lett 6(5):1390\u20131396","journal-title":"Oncol Lett"},{"key":"212_CR15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG (1998) Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936\u2013942","journal-title":"Mayo Clin Proc"},{"key":"212_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"212_CR17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.semcancer.2006.10.009","volume":"16","author":"ES Arn\u00e9r","year":"2006","unstructured":"Arn\u00e9r ES, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420\u2013426","journal-title":"Semin Cancer Biol"},{"key":"212_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-2797(97)00148-8","volume":"111\u2013112","author":"G Powis","year":"1998","unstructured":"Powis G, Kirkpatrick DL, Angulo M, Baker A (1998) Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem Biol Interact 111\u2013112:23\u201334","journal-title":"Chem Biol Interact"},{"key":"212_CR19","first-page":"2281","volume":"60","author":"A S\u00f6derberg","year":"2000","unstructured":"S\u00f6derberg A, Sahaf B, Ros\u00e9n A (2000) Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 60:2281\u20132289","journal-title":"Cancer Res"},{"key":"212_CR20","first-page":"4293","volume":"55","author":"A Yokomizo","year":"1995","unstructured":"Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K (1995) Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55:4293\u20134296","journal-title":"Cancer Res"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-015-0212-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0212-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:28:17Z","timestamp":1566242897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-015-0212-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,17]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s10014-015-0212-x","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,17]]}}}